You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adoptive transfer

Showing 1 - 25 of 2,644
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

After Adoptive Transfer of Genetically Modified Cell Products

Recruiting
  • Relapsed Hematologic Malignancy
  • Refractory Hematologic Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Feb 6, 2023

    Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)

    Active, not recruiting
    • Prostate Cancer
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Nov 28, 2022

    Uveal Tumors, Melanoma, Uveal Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

    Recruiting
    • Uveal Neoplasms
    • Melanoma, Uveal
    • Tumor Infiltrating Lymphocytes (TIL)
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 21, 2022

    Biliary Tract Cancer, Cholangiocarcinoma, Biliary Tract Tumors Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))

    Recruiting
    • Biliary Tract Cancer
    • +2 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Pittsburgh, Pennsylvania
      Allyson Welsch
    Jul 21, 2022

    Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

    Recruiting
    • Gastric Cancer
    • +9 more
    • Tumor Infiltrating Lymphocytes (TIL)
    • Fludarabine + Cyclophosphamide combination
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Jul 21, 2022

    HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

    Recruiting
    • HNSCC
    • +5 more
    • DP CD8 TIL
    • +2 more
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 5, 2023

    Lupus Nephritis, Type 1 Diabetes Trial in Cairo (autologous adoptive T regulatory cell transfer.)

    Not yet recruiting
    • Lupus Nephritis
    • Type 1 Diabetes Mellitus
    • autologous adoptive T regulatory cell transfer.
    • Cairo, Egypt
      Ain shams university, faculty of medicine
    Sep 30, 2022

    Metastatic Melanoma Trial in Tampa (procedure, drug, other)

    Active, not recruiting
    Has Results
    • Metastatic Melanoma
    • Surgery
    • +3 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    Jan 10, 2023

    Solid Tumor, Adult Trial in Lausanne (biological, drug, radiation)

    Recruiting
    • Solid Tumor, Adult
    • NeoTIL
    • +4 more
    • Lausanne, Vaud, Switzerland
      centre hospitalier universitaire vaudois (CHUV)
    Jun 23, 2022

    Metastatic Melanoma Trial in Tampa (drug, procedure, biological)

    Active, not recruiting
    Has Results
    • Metastatic Melanoma
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Nov 8, 2022

    Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)

    Terminated
    • Serologically Active Adult Systemic Lupus Erythematosus
    • Autologous EBV specific CTL infusion
    • Nantes, France
    • +2 more
    Mar 24, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Philadelphia (MOv19-BBz CAR T cells, Alpha Folate

    Recruiting
    • Ovarian Cancer
    • +2 more
    • MOv19-BBz CAR T cells
    • Alpha Folate Receptor expression test
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Sep 12, 2022

    Hiv, HIV, Immune Deficiency Trial in Minneapolis (Haploidentical Natural Killer (NK) Cells)

    Completed
    • Hiv
    • +2 more
    • Haploidentical Natural Killer (NK) Cells
    • Minneapolis, Minnesota
      University of Minnesota
    Apr 21, 2021

    Advanced Melanoma Trial in Basel (Combination of Tumor-infiltrating lymphocyte transfer with ANV419)

    Not yet recruiting
    • Advanced Melanoma
    • Combination of Tumor-infiltrating lymphocyte transfer with ANV419
    • Basel, Switzerland
      University Hospital Basel
    May 19, 2023

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix (Autologous MUC1-activated T-cells,

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Phoenix, Arizona
      Mayo Clinic Hospital in Arizona
    Jan 4, 2023

    Solid Tumor, Adult Trial in Lausanne (TIL, Cyclophosphamide, Fludarabine)

    Terminated
    • Solid Tumor, Adult
    • TIL
    • +4 more
    • Lausanne, Vaud, Switzerland
      CHUV Oncology Department
    Mar 16, 2021

    Metastatic Melanoma Trial in Lausanne (TIL, Cyclophosphamide, Fludarabine)

    Active, not recruiting
    • Metastatic Melanoma
    • TIL
    • +4 more
    • Lausanne, Vaud, Switzerland
      CHUV Oncology Department
    Oct 11, 2021

    Neuroblastoma, Diffuse Intrinsic Pontine Glioma Trial in Gainesville, Charlotte (Tumor-specific ex vivo expanded autologous

    Recruiting
    • Neuroblastoma
    • Diffuse Intrinsic Pontine Glioma
    • Tumor-specific ex vivo expanded autologous lymphocyte transfer (TTRNA-xALT)
    • Gainesville, Florida
    • +1 more
    Apr 20, 2022

    Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)

    Active, not recruiting
    • Malignant Neoplasm
    • aldesleukin
    • +7 more
    • Los Angeles, California
      University of California at Los Angeles (UCLA )
    Dec 1, 2022

    Tumor Metastasis Trial in Taipei (autologous IKDC-like cells)

    Completed
    • Neoplasm Metastasis
    • autologous IKDC-like cells
    • Taipei, Taiwan
      Tri-Service General Hospital
    Feb 17, 2021

    Advanced NSCLC, Chemo Trial in Xi'an (Chemotherapy, Adoptive TKC transfer therapy)

    Recruiting
    • Advanced Non-small Cell Lung Cancer
    • Chemotherapy
    • Xi'an, Shanxi, China
      Tangdu Hospital, Fourth Military Medical University
    Jul 26, 2021

    Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

    Recruiting
    • Lymphoma
    • +2 more
    • Kappa CD28 T cells
    • Houston, Texas
    • +1 more
    Jan 31, 2022

    Advanced Melanoma Trial in Basel (Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2)

    Recruiting
    • Advanced Melanoma
    • Combination of TIL Transfer with anti-PD-1 Therapy and low dose IL-2
    • Basel, Switzerland
      Division of Medical Oncology and Cancer Immunology, University H
    Aug 3, 2021

    Malignant Melanoma Trial in Herlev (Cyclophosphamide, Fludarabine Phosphate, Multiple Antigen Specific Endogenously derived T

    Recruiting
    • Malignant Melanoma
    • Herlev, Denmark
      National Center for Cancer Immune Therapy (CCIT-DK)
    Sep 14, 2021

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Durham (Idarubicin, Cytarabine, DLI)

    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Durham, North Carolina
      Duke University Medical Center
    Dec 1, 2020